Morocco is preparing to overhaul the regulatory framework governing marketing authorizations (AMM) for pharmaceutical products, with implications that could reshape the market for generic medicines and ease the financial burden on patients and social insurance funds. The reform is linked to an examination of bill 27.26, which amends the country’s pharmaceutical code and opens the […]
